Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PANITUMUMAB vs PANOBINOSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PANITUMUMAB vs PANOBINOSTAT: Safety Overview

Metric PANITUMUMAB PANOBINOSTAT
Total FAERS Reports 10,876 1,820
Deaths Reported 1,666 517
Death Rate 15.3% 28.4%
Hospitalizations 3,121 623
Average Patient Age 63.0 yrs 61.8 yrs
% Female Patients 36.9% 49.7%
FDA Approval Date N/A Feb 23, 2015
Manufacturer Amgen Inc N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Discontinued